Document: Methylphenidate, prolonged-release tablet 18 mg, 27 mg, 36 mg and 54 mg and modified release capsule 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg and 60 mg product-specific bioequivalence guidance-2025/2/10

Document: Seizing opportunities in a changing medicines landscape: The European medicines agencies network strategy 2028 (final)-2025/3/18

Document: European Medicines Agency’s data protection notice for EudraVigilance Human (EV)-2025/4/22

Document: Applicant / marketing authorisation holder change of contact person for product invented name / product number template-2025/6/2

国家药监局关于心神宁胶囊转换为非处方药的公告（2025年第64号）-2025/7/8

Document: Procedural advice on paediatric applications-2025/8/8

Document: Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2025-2025/9/25

国家药监局关于发布医疗器械生产质量管理规范的公告（2025年第107号）-2025/11/4

Document: EMA decision on adoption by analogy of Commission decision C (2025) 2495-2025/12/3

2026年兴奋剂目录公告-2026/1/7